期刊文献+

地高辛对全因死亡率影响的荟萃分析 被引量:2

Effect of Digoxin on the rate of all-cause mortality: A meta-analysis
下载PDF
导出
摘要 目的:荟萃分析地高辛对全因死亡率的影响。方法:收集Medline以及Cochrane数据文献,通过I^2统计量进行异质性检验,用随机效应模型分析地高辛对全因死亡的风险,得到合并效应指标风险比及其95%可信区间。结果:最终纳入文献10篇,总样本量24 865人,地高辛组的全因死亡率风险与对照组并无明显差异(HR1.04,95%CI 0.85~1.28,P=0.68)。结论:临床应用中地高辛并未显著升高全因死亡率。 Objective:To investigate the effect of Digoxin on rate of all-cause mortality by meta-analysis. Methods:The articles were collected from Medline and Cochrane databases. Heterogeneity was analyzed by I2 statistics. The risk of Digoxin on all-cause mortality was analyzed by random effect model to give the hazard ratio ( HR) of combined effect indicators and its 95% confidence interval. Results:Ten studies were included finally, with a total sample size of 24865. There was no significant difference in the risk of all-cause mortality between the Digoxin group and the control group (HR1.04,95% CI 0.85~1.28,P=0.68). Conclusion:Use of Digoxin in clinical practice does not significantly increase the all-cause mortality.
出处 《广州医科大学学报》 2016年第3期11-14,共4页 Academic Journal of Guangzhou Medical University
关键词 地高辛 全因死亡率 荟萃分析 digoxin all-cause mortality meta-analysis
  • 相关文献

参考文献2

二级参考文献17

  • 1蔡明虹,储小曼,王淑娟.老年心衰病人地高辛药物动力学的研究及合理应用[J].中国医院药学杂志,1994,14(12):546-548. 被引量:20
  • 2MARTINDALE .The extra pharmacopoeia[S]. 31 Editer,1996.856~859.
  • 3曾繁典. 治疗心功能不全药物[A]见:. 李家泰主编. 临床药理学. 第二版. 北京:人民卫生出版社,1998.914-919.
  • 4Seligmann H,Ezra D. Didoxin intoxication due to unadjusted loading dose in renal failure[J]. Havrefuah ,1993, 124(7):412.
  • 5Cheng JW, Charland SL, Shaw LM, et al. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay[J]. Pharmacotherapy,1997,17(3): 584~90.
  • 6Odani A, Hashimoto Y, Otsuki Y, et al. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy [J]. Clirl Pharmacol Ther, 1997, 62: 287-292.
  • 7Xiao ZS, Goldstein JA, Xie HG, et al. Differences in the incidence of the CYP2C19 polymorphism affecting the S-naephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP'2C19 mutant allele[J]. J Pharmacol Exp Ther, 1997, 281 : 604-609.
  • 8Soskin DP, Kane AJ, Stem TA. Phenytoin toxicity secondary to an oxcarbazepine-phenytoia 2C19 interaction [J]. Psychosomatics, 2010, 51: 532-535.
  • 9Kesavan R, Narayan SK, Adithan C. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients [J]. Eur J Clin Pharmacol, 2010, 66: 689-696.
  • 10中华医学会.临床诊疗指南:癫痫病分册[M].北京:人民卫生出版社,2012:4-5.

共引文献8

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部